Börse:
8,792€
3,16%
Echtzeit-Aktienkurs Recro Pharma
Bid:
8,605€
Ask:
8,978€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 191,65 Mio. EUR (21,80 Mio. x 8,792€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 2,41 | 2,34 | 2,48 |
| KGV | - | - | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Recro Pharma Aktie
Börsenkurse Recro Pharma
| Euro Indikation | 8,605€ | 0 | 8,978€ | 0 | 8,792€ | 3,16% |
| Börse Stuttgart | 8,605€ | 0 | 8,978€ | 0 | 8,792€ | 2,00% |
| Tradegate | - | - | - | - | - | - |
| Dollar Indikation | 9,592$ | 0 | 10,008$ | 0 | 9,800$ | -1,21% |
Fundamentaldaten der Recro Pharma Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 77,35 Mio. | -62,29 Mio. | -79,72 Mio. | -3,90 | 0,00% | - | 2,48 |
| 2017 | 71,83 Mio. | -51,96 Mio. | -50,08 Mio. | -2,63 | 0,00% | - | 2,34 |
| 2016 | 69,34 Mio. | -31,31 Mio. | -30,21 Mio. | -2,82 | 0,00% | - | 2,41 |
Profil der Recro Pharma Aktie
Recro Pharma, Inc. is a pharmaceutical company, whcih is focused on products for hospitals and ambulatory care settings. The company is developing non-opioid products for treatment of serious acute pain. It offers drug solutions for cancer, musculoskeletal disorders and peripheral neuropathy, cancer breakthrough and acute post-operative pain. The company's products include Dex-INR and Fadolmidine, which is under development. Recro Pharma was founded by Geraldine A. Henwood on November 15, 2007 and is headquartered in Malvern, PA.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen